Savolitinib found to help treatment-resistant lung cancer in combo with AZ’s Tagrisso
The news was announced at the American Association for Cancer Research (AACR) annual meeting.
Read More
Tag: ChiMed
AstraZeneca’s Imfinzi gets speedy US review for lung cancer
US regulators have accepted an application by AstraZeneca and MedImmune to expand the scope of Imfinzi to include patients with a certain form of lung cancer.
Read More
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
